InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-38.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Etherington Robert Dee, Chairman & CEO. Officer active across 1 company, notably Clene Inc.. Cumulatively, 6 filings have been logged. Breakdown: 2 buys · 1 sell. Total volume traded: €170k. Activity tracked since 30 June 2021. The latest transaction was disclosed on 30 September 2024 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
10,000 shares@ US$4.7517.3% of flowCommon StockSEC:0001562180-24-007036:0
Ideal exit: 27 Jun 2025 (T+270)
27,320 shares@ US$3.0030.8% of flowCommon StockSEC:0001562180-24-005867:0
25,000 shares@ US$0.817.5% of flowCommon StockSEC:0001562180-23-005506:0
Ideal exit: 22 Mar 2024 (T+270)
23,483 shares@ US$4.7244.4% of flowCommon StockSEC:0001562180-22-005708:0
80,076 shares0Common StockSEC:0001562180-21-004605
80,076 shares0Common StockSEC:0001562180-21-004605:0
6 of 6 declarations
About Etherington Robert Dee
Robert Dee Etherington is the Chief Executive Officer of Clene Inc. He leads the company in the biotechnology sector, focusing on the development of innovative treatments. With a strong background in the industry, Robert Dee Etherington is responsible for the overall strategy and operational direction of the company.
